Publication | Open Access
A Novel <sup>111</sup>In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
132
Citations
25
References
2015
Year
We developed an (111)In-radiolabeled anti-PSMA Nanobody, showing good tumor targeting, low uptake in nontarget tissues, and low renal retention, allowing excellent SPECT/CT imaging of PCa within a few hours after injection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1